SB 483 Michigan Senate · 2023-2024 Regular Session

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

Bill status passed 3 of 5 stages cleared

Introduction

Sep 2023

Committee Review

Oct 2023

Senate Passage

Oct 2023

House Passage

Governor

Introduced Sep 12, 2023 Last action Oct 4, 2023

Floor votes · Senate Oct 4, 2023

How they voted

20–17

Passed · 1 other

Total votes 38

Oct 4, 2023

D Democratic20

20 Yea

100% Yea

R Republican18

17 Nay 1

94% Nay

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Oct 4, 2023

Committee

referred to Committee on Insurance and Financial Services

lower

Oct 4, 2023

Introduced

received on 10/04/2023

lower

Oct 4, 2023

Upper · Passed

PASSED ROLL CALL # 498 YEAS 20 NAYS 17 EXCUSED 0 NOT VOTING 1

upper

Oct 4, 2023

Amended

AMENDMENT(S) DEFEATED

upper

Oct 4, 2023

Upper · Passed

AMENDMENT(S) ADOPTED

upper

Oct 3, 2023

Upper · Passed

SUBSTITUTE (S-1) CONCURRED IN

upper

Oct 3, 2023

Upper · Passed

REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE (S-1)

upper

Sep 28, 2023

Committee

REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE (S-1)

upper

Sep 28, 2023

Upper · Passed

REPORTED FAVORABLY WITH SUBSTITUTE (S-1)

upper

Sep 12, 2023

Committee

REFERRED TO COMMITTEE ON FINANCE, INSURANCE, AND CONSUMER PROTECTION

upper

Sep 12, 2023

Introduced

INTRODUCED BY SENATOR DARRIN CAMILLERI

upper

1 primary · 17 co-sponsors